CG
GILD icon

Cutler Group’s Gilead Sciences GILD Stock Holding History

Cutler Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,570
Closed -$1.7M – 4123
2022
Q4 		$1.76M Sell
20,570
-20,717
-50% -$1.64M 0.15% 145
2022
Q3 		$2.55M Buy
41,287
+28,681
+228% +$1.81M 0.17% 114
2022
Q2 		$779K Sell
12,606
-28,433
-69% -$1.76M 0.05% 394
2022
Q1 		$2.44M Buy
41,039
+36,353
+776% +$2.32M 0.13% 170
2021
Q4 		$340K Buy
+4,686
New +$323K 0.01% 958
2021
Q2 		– Sell
-2,387
Closed -$159K – 5921
2021
Q1 		$154K Sell
2,387
-31,799
-93% -$2.05M 0.01% 1444
2020
Q4 		$1.99M Buy
34,186
+100
+0.3% +$6.03K 0.09% 211
2020
Q3 		$2.15M Sell
34,086
-7,284
-18% -$505K 0.13% 153
2020
Q2 		$3.18M Buy
41,370
+6,132
+17% +$470K 0.21% 90
2020
Q1 		$2.63M Buy
35,238
+26,802
+318% +$1.85M 0.14% 141
2019
Q4 		$548K Buy
8,436
+3,500
+71% +$228K 0.03% 419
2019
Q3 		$312K Sell
4,936
-5,063
-51% -$331K 0.03% 506
2019
Q2 		$675K Sell
9,999
-6,780
-40% -$446K 0.06% 280
2019
Q1 		$1.09M Sell
16,779
-10,149
-38% -$675K 0.11% 168
2018
Q4 		$1.68M Sell
26,928
-11,564
-30% -$808K 0.16% 103
2018
Q3 		$2.97M Buy
38,492
+236
+0.6% +$17.8K 0.21% 85
2018
Q2 		$2.71M Buy
38,256
+9,164
+32% +$647K 0.22% 84
2018
Q1 		$2.19M Sell
29,092
-12,254
-30% -$974K 0.19% 98
2017
Q4 		$2.96M Buy
41,346
+8,727
+27% +$663K 0.12% 109
2017
Q3 		$2.64M Sell
32,619
-16,354
-33% -$1.25M 0.1% 160
2017
Q2 		$3.47M Sell
48,973
-114,688
-70% -$7.63M 0.13% 134
2017
Q1 		$11.1M Buy
163,661
+158,271
+2,936% +$11.1M 0.46% 31
2016
Q4 		$385K Sell
5,390
-159,881
-97% -$11.9M 0.01% 854
2016
Q3 		$13.1M Sell
165,271
-48,927
-23% -$3.97M 0.59% 20
2016
Q2 		$17.9M Buy
214,198
+136,768
+177% +$12.1M 0.91% 11
2016
Q1 		$7.11M Sell
77,430
-19,436
-20% -$1.75M 0.47% 20
2015
Q4 		$9.8M Buy
+96,866
New +$10.1M 0.55% 16

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's GILD Position: Q1 2023 in Review

Cutler Group sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 20,570 shares — an estimated $1.7M sold.

Cutler Group first reported a position in GILD in Q4 2015 and held it in 27 quarters. The position peaked at $17.9M in Q2 2016. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Cutler Group reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 20,570 Gilead Sciences shares in Q1 2023, an estimated $1.7M.
  • Cutler Group first reported a position in Gilead Sciences in Q4 2015 and held it in 27 quarters.
  • Cutler Group's Gilead Sciences position peaked at $17.9M in Q2 2016.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.